Yehia Hashad - Mar 1, 2023 Form 4 Insider Report for Bausch & Lomb Corp (BLCO)

Role
EVP, R&D and CMO
Signature
/s/ Debra E. Levin
Stock symbol
BLCO
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/3/2023, 04:01 PM
Previous filing
Dec 1, 2022
Next filing
Jul 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLCO Common Shares, No Par Value Award $0 +17.7K +25.41% $0.00 87.4K Mar 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCO Non-Qualified Stock Options (right to purchase) Award $0 +56.7K $0.00 56.7K Mar 1, 2023 Common Shares, No Par Value 56.7K $17.96 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation.
F2 Reflects the grant of stock options to purchase Common Shares under the Plan.
F3 The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement.
F4 The stock options will expire on the tenth anniversary of the grant date.